11:08 AM EST, 01/25/2022 (MT Newswires) --
In continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and biopharmaceutical company Biofrontera (BFRA), which climbed 7.1% and 6.8%, respectively. They were followed by kidney dialysis company Fresenius Medical Care (FMS) and biopharmaceutical company ERYTECH Pharma (ERYP), which rose 4.5% and 2.5%.
The decliners in continental Europe were led by biopharmaceutical company Calliditas Therapeutics (CALT) and optical bonding company VIA optronics (VIAO), which fell 5.9% and 5.8%, respectively. They were followed by luxury ecommerce platform MYT Netherlands Parent (MYTE) and semiconductor company ASML Holding (ASML), which dropped 5.7% and 4.7%.
In the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and Trinity Biotech (TRIB), which climbed 9.2% and 4.3%, respectively. They were followed by educational publisher Pearson (PSO) and bank holding company Lloyds Banking Group (LYG), which rose 2.8% and 2.4%.
The decliners in the UK and Ireland were led by software firm Endava (DAVA) and biopharmaceutical company Mereo BioPharma Group (MREO), which lost 4.6% and 4.2%, respectively. They were followed by biopharmaceutical companies MorphoSys (MOR) and Adaptimmune Therapeutics (ADAP), which were down 3.9% and 3.4%.
Copyright © 2022 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.